*** PLEASE alert your friends—Our own continued health and longevity may depend on Steve continuing his work.***
This call for support was also posted by Ilia Stambler on the Longevity Alliance Website, and organized on YouCaring.com by John M. Adams. Eric Schulke has also helped tremendously in spreading the word about the Fundraiser.
Since founding the Los Angeles Gerontology Research Group in 1990, Dr. L. Stephen Coles M.D., Ph.D., has worked tirelessly to develop new ways to slow and ultimately reverse human aging.
Everyone active in the LA-GRG or the Worldwide GRG Discussion Group have benefited from his expertise. His continual reporting of news about the latest developments to the List and his work in areas such as gathering blood samples for a complete genome analysis of the oldest people in the world (supercentenarians, aged 110+) is ground breaking and far ahead of anything that has ever been accomplished before. Publication of this work is expected in collaboration with Stanford University before the end of the year. Other accomplishments are equally notable
BRIEF summary of his work: L. Stephen Coles, M.D. Ph.D — Cited in more than 250 scientific articles — Profiled as notable person in Wikipedia — Many other contributions to aging research and advancing long, healthy life
Steve Coles was diagnosed with Adenocarcinoma (Pancreatic Cancer) at the head of the pancreas on Christmas Eve of last year. Pancreatic cancer is particularly insidious. He underwent a Whipple (Surgical) Procedure on January 3rd that produced a beneficial result. The tumor’s complete obstruction to the common bile duct that had caused jaundice and severe pruritus (skin itching leading to scratching to the point of bleeding) was almost immediately reversed in two days. His subsequent chemotherapy with Gemzar over the past three months will hopefully prevent metastases from spreading to other organs. But we won’t know his prognosis until June 7th when a CT Scan will be compared with a baseline scan performed before the start of chemo interpreted by a cancer radiologist.
We now have the opportunity to carry out a personalized chemo treatment regimen created by a start-up company called Champions Oncology in Baltimore, MD; USA affiliated with the Johns Hopkins School of Medicine. Champions is a world class organization that will analyze the tissue sample that has already been sent to them. Then, a custom treatment program will be prescribed for Steve based on a mouse model, since each tumor is unique and pure test tube trials have not been shown to be effective.
Champions Oncology’s service is to test in mice what can work for Dr. Coles. This is done through two steps:
(1) To implant Dr. Coles’s cancer on mice. (This part has been successfully carried out, and it will allow us to test nine different treatment protocols on Dr. Coles’s specific tumor tissue in mice).
(2) Test the treatments on the mice (The treatments have been defined with Dr. James P. Watson, Dr. Coles, and his oncologists.)
Dr. Joao Pedro de Magalhes of Liverpool, UK was the first to propose employing the services of Champions Oncology. They have a good track record. The biggest risk is that the process normally takes so long that the patient dies before the results can be obtained (especially with such an aggressive, malignant cancer, as Dr. Coles’s). Luckily, this part went right. Also, there is a risk is that Step-1 won’t work. Luckily for us, this part went right, too. Therefore, so far, it seems that choosing Champions Oncology’s approach was the right choice. We can’t be sure that Step-2 will be as successful, but we need to try.
In addition to his medical team here in the U.S., our international friends have been active on his behalf. They successfully negotiated a 60 percent reduction in cost.
NOW, YOU CAN HELP IN TWO WAYS:
(1) CONTRIBUTE TO THIS FUND
Time is of the essence. The good people at Champions Oncology have agreed to begin the analysis immediately.
Steve Coles needs your support.
It may make THE difference. Please dig deep and support him by contributing to the fund.
*** Our own continued health and longevity may depend on Steve continuing his work.***
(2) SEND REFERRALS TO CHAMPIONS ONCOLOGY
Champions Oncology is an early-stage for-profit company. Champions is not a philanthropy. Like many companies offering breakthrough technologies, it has light bills to pay, payroll to make on time, and many other typical expenses.
Please think of any oncologists how may refer patients to Champions, then contact any of the individuals listed below so we may get life-saving information about Champions into their hands. Champions is particularly well set up to accommodate physicians and patients in the Eastern U.S., Germany, France, Brazil, and Japan.
We wish to acknowledge the GRG (the Gerontology Research Group—A discussion group of ~400 members worldwide.
We owe a special thank you to The International Longevity Alliance Movement for their support.
Contacts:
1. Edouard Debonneuil edebonneuil@yahoo.fr France Skype ID: edebonneuil
2. Daniel Wuttke D.A.Wuttke@liverpool.ac.uk Germany Skype: admiral_atlan
3. Ilia Stambler ilia.stambler@gmail.com Israel Skype: iliastam
4. John M. (Johnny) Adams JAdams@AgingInterventionFoundation.org
U.S. (949) 922‑9786 Skype: agingintervention
Updates 06/03/2013
by John M. (Johnny) Adams
IMPORTANT MESSAGE: Dr. Coles has received a contribution and is forwarding it directly to Champions Oncology.
So as of now, 10:20 am PDT, we have $6175 of the needed $10,000!
I have contacted YouCaring and asked how to change the “$1475 raised of $10000 goal”.
Supporters
Franco Cortese
donated$100.00
Monday, June 03, 2013
PLEASE donate ANYTHING you can to help save the life of L. Stephen Coles, who has spent his entire professional career trying to save yours!
Aubrey de Grey
donated$300.00
Monday, June 03, 2013
Anonymous
Offline Donation
donated$5,000.00
Monday, June 03, 2013
donated Hidden Amount
Monday, June 03, 2013
Anonymous
donated Hidden Amount
Monday, June 03, 2013
Sven Bulterijs
donated$15.00
Monday, June 03, 2013
Anonymous
donated Hidden Amount
Sunday, June 02, 2013
kg goldberger
donated$20.00
Sunday, June 02, 2013
prayers are on the way for more than 65% of deaths. Aging is a cause of adult cancer, stroke and many others age related diseases. Researchers fighting aging are the best people, they are fighting for all of us. Let’s pay them back!
Bijan Pourat MD
donated$250.00
Saturday, June 01, 2013
Maxim Kholin
donated Hidden Amount
Saturday, June 01, 2013
Aging is a disease. Aging is responsible
Anonymous
donated$60.00
Saturday, June 01, 2013
Nils Alexander Hizukuri
donated$30.00
Saturday, June 01, 2013
All the best!
Anonymous
donated$40.00
Saturday, June 01, 2013
Danny Bobrow
donated Hidden Amount
Saturday, June 01, 2013
Steve, win this fight for us all. I send you healing thoughts.
Danny Steve, friends and family, but it is an outstanding, real-world example of the advancing frontier of science and medicine. The entire life-extension community should rally in support of this effort for Steve and for the acquisition of important scientific knowledge.
Cliff Hague
donated $100.00
Saturday, June 01, 2013
Best wishes for a speedy recovery.
Tom Coote
donated $100.00
Friday, May 31, 2013
With Best Wishes!
Anonymous
donated$100.00
Friday, May 31, 2013
Allen Taylor
donated$25.00
Friday, May 31, 2013
Gunther Kletetschka
donated Hidden Amount
Friday, May 31, 2013
john mccormack, Australia
donated$50.00
Friday, May 31, 2013
phil kernan
donated$100.00
Friday, May 31, 2013
Gary and Marie Livick
donated$100.00
Friday, May 31, 2013
ingeseim
donated Hidden Amount
Friday, May 31, 2013
TeloMe Inc.
donated$100.00
Friday, May 31, 2013
Not only is this an important cause for
-Preston Estep, Ph.D.
CEO and Chief Scientific Officer, TeloMe, Inc.
Anonymous
donated$5.00
Thursday, May 30, 2013
Anonymous
donated$60.00
Thursday, May 30, 2013
Larry Abrams
donated$100.00
Thursday, May 30, 2013
Anonymous
donated Hidden Amount
Thursday, May 30, 2013
Anonymous
donated Hidden Amount
Thursday, May 30, 2013
Anonymous
donated Hidden Amount
Thursday, May 30, 2013
Anonymous
donated Hidden Amount
Wednesday, May 29, 2013
